Lara Allison Ray

Title(s)Professor, Psychology
SchoolCollege of Letters and Science
vCardDownload vCard
    Other Positions
    Title(s)Professor, Psychiatry and Biobehavioral Sciences


    Collapse Research 
    Collapse Research Activities and Funding
    Integrating findings across stages of medication development for AUD
    NIH R21AA029771Sep 20, 2021 - Aug 31, 2023
    Role: Principal Investigator
    Identifying treatment responders in medication trials for AUD using machine learning approaches
    NIH R03AA029244Apr 10, 2021 - Mar 31, 2023
    Role: Principal Investigator
    A Novel Human Laboratory Model for Screening Medications for Alcohol Use Disorder
    NIH R21AA027180Sep 20, 2019 - Aug 31, 2022
    Role: Principal Investigator
    Clinical neuroscience of alcoholism: integrating neuroscience and clinical trials
    NIH K24AA025704Sep 15, 2018 - Aug 31, 2023
    Role: Principal Investigator
    A randomized controlled clinical trial of the neuroimmune modulator ibudilast for the treatment of alcohol use disorder
    NIH R01AA026190May 15, 2018 - Feb 28, 2022
    Role: Principal Investigator
    Combining varenicline and naltrexone for smoking cessation and drinking reduction
    NIH R01DA041226Sep 1, 2015 - May 31, 2019
    Role: Principal Investigator
    Perceived alcohol reward value and risk: Neural correlates and treatment effects
    NIH R21AA023669Apr 1, 2015 - Mar 31, 2018
    Role: Co-Principal Investigator
    Modeling alcohol reward and reinforcement in the human laboratory
    NIH R21AA022752Sep 10, 2014 - Aug 31, 2017
    Role: Principal Investigator
    Optimizing naltrexone for individuals of East Asian descent
    NIH R01AA021744Sep 1, 2013 - Jun 30, 2017
    Role: Principal Investigator
    Development of Ibudilast as a Novel Treatment for Alcoholism
    NIH R21AA022214Jul 15, 2013 - Jun 30, 2015
    Role: Principal Investigator
    Pharmacogenetics of Natlrexone for Methamphetamine Use Disorder
    NIH R21DA029831Sep 15, 2011 - Aug 31, 2013
    Role: Principal Investigator
    Neuroimaging probes of medication response in smokers
    NIH R03DA030898Sep 20, 2010 - Aug 31, 2012
    Role: Principal Investigator
    Integrating Laboratory Neuroimaging Phenotypes
    NIH R03AA019569Sep 25, 2009 - Aug 31, 2011
    Role: Principal Investigator
    Genetic Correlates of Alcohol Use Disorders
    NIH F31AA014847Apr 1, 2004 - Mar 31, 2007
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Alcohol Use Among Treatment-Seeking Individuals with Opioid Use Disorder. J Stud Alcohol Drugs. 2023 Apr 19. Baskerville WA, Grodin EN, Lin J, Miotto K, Mooney LJ, Ray LA. PMID: 37096768.
      View in: PubMed   Mentions:    Fields:    
    2. Alcohol Craving and Severity are Associated with Dorsal Anterior Cingulate Choline Levels in Individuals with an Alcohol Use Disorder. Alcohol Alcohol. 2023 Mar 20. Grodin EN, Burnette EM, O'Neill J, Alger J, Ray LA. PMID: 36939375.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. The vicious cycle between (neuro)inflammation and alcohol use disorder: An opportunity to develop new medications? Alcohol Clin Exp Res. 2023 Mar 07. Lékó AH, Ray LA, Leggio L. PMID: 36882163.
      View in: PubMed   Mentions:    Fields:    
    4. Efficacy of Cognitive Behavioral Therapy for Alcohol and Other Drug Use Disorders: Is a One-Size-Fits-All Approach Appropriate? Subst Abuse Rehabil. 2023; 14:1-11. Magill M, Kiluk BD, Ray LA. PMID: 36844999; PMCID: PMC9948631.
      View in: PubMed   Mentions:
    5. Hazardous drinking and alcohol use disorders. Nat Rev Dis Primers. 2022 12 22; 8(1):80. MacKillop J, Agabio R, Feldstein Ewing SW, Heilig M, Kelly JF, Leggio L, Lingford-Hughes A, Palmer AA, Parry CD, Ray L, Rehm J. PMID: 36550121.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Cross-substance primed and cue-induced craving among alcohol and cannabis co-users: An experimental psychopharmacology approach. Exp Clin Psychopharmacol. 2022 Dec 19. Venegas A, Ray LA. PMID: 36534416.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    7. Combination treatment with varenicline and naltrexone reduces World Health Organization risk drinking levels. Alcohol Clin Exp Res. 2022 12; 46(12):2258-2266. Nieto SJ, Enders CK, Witkiewitz K, O'Malley SS, Ray LA. PMID: 36515648.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    8. Translational models of addiction phenotypes to advance addiction pharmacotherapy. Ann N Y Acad Sci. 2023 01; 1519(1):118-128. Ray LA, Nieto SJ, Grodin EN. PMID: 36385614.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. The Brief Alcohol Use Disorder Severity Scale: An Initial Validation Evaluation. Alcohol Alcohol. 2022 Nov 11; 57(6):762-767. Donato S, Nieto S, Ray LA. PMID: 36063825; PMCID: PMC9651986.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Pain Catastrophizing Is Associated With Increased Alcohol Cue-Elicited Neural Activity Among Individuals With Alcohol Use Disorder. Alcohol Alcohol. 2022 Nov 11; 57(6):727-733. Nieto SJ, Grodin EN, Burnette EM, Cahill CM, Ray LA. PMID: 35788255; PMCID: PMC9651980.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Baseline C-reactive protein levels are predictive of treatment response to a neuroimmune modulator in individuals with an alcohol use disorder: a preliminary study. Am J Drug Alcohol Abuse. 2022 Oct 25; 1-12. Grodin EN, Meredith LR, Burnette EM, Miotto K, Irwin MR, Ray LA. PMID: 36282988.
      View in: PubMed   Mentions:    Fields:    
    12. Characteristics associated with treatment seeking for smoking cessation among heavy-drinking research participants. Front Psychiatry. 2022; 13:951364. Green R, Lin J, Montoya AK, Bello MS, Grodin EN, Ryu H, Ho D, Leventhal AM, Ray LA. PMID: 36245856; PMCID: PMC9554538.
      View in: PubMed   Mentions:
    13. The Effects of Menstrual Cycle Hormones on Responses to Varenicline and Naltrexone Among Female Heavy Drinking Smokers. Alcohol Alcohol. 2022 Sep 10; 57(5):609-614. Green R, Roche DJO, Ray LA. PMID: 35470371; PMCID: PMC9465527.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. A Meta-Regression of Trial Features Predicting the Effects of Alcohol Use Disorder Pharmacotherapies on Drinking Outcomes in Randomized Clinical Trials: A Secondary Data Analysis. Alcohol Alcohol. 2022 Sep 10; 57(5):589-594. Grodin EN, Donato S, Du H, Green R, Bujarski S, Ray LA. PMID: 35229869; PMCID: PMC9465523.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Cannabis and alcohol co-use: The effects of intensity of cannabis use among heavy drinkers. Addict Behav. 2022 Dec; 135:107443. Venegas A, Du H, Cooper ZD, Ray LA. PMID: 35932601.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    16. Effects of ibudilast on central and peripheral markers of inflammation in alcohol use disorder: A randomized clinical trial. Addict Biol. 2022 07; 27(4):e13182. Grodin EN, Nieto SJ, Meredith LR, Burnette E, O'Neill J, Alger J, London ED, Miotto K, Evans CJ, Irwin MR, Ray LA. PMID: 35754106; PMCID: PMC9888600.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    17. Global sleep quality is associated with tonic craving, but not cue-induced craving. Addict Behav. 2022 10; 133:107372. Baskerville WA, Grodin EN, Venegas A, Ray LA. PMID: 35660858.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Alcohol use trajectories among U.S. adults during the first 42 weeks of the COVID-19 pandemic. Alcohol Clin Exp Res. 2022 06; 46(6):1062-1072. Leventhal AM, Cho J, Ray LA, Liccardo Pacula R, Lee BP, Terrault N, Pedersen E, Lee JO, Davis JP, Jin H, Huh J, Wilson JP, Whaley RC. PMID: 35532741; PMCID: PMC9246926.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    19. Cannabis use and subjective response to alcohol in the human laboratory. Drug Alcohol Depend. 2022 07 01; 236:109481. Nieto SJ, Venegas A, Hudson J, Ray LA. PMID: 35523112; PMCID: PMC9203930.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    20. The effect of neuroimmune modulation on subjective response to alcohol in the natural environment. Alcohol Clin Exp Res. 2022 05; 46(5):876-890. Meredith LR, Grodin EN, Montoya AK, Miranda R, Squeglia LM, Towns B, Evans C, Ray LA. PMID: 35362101.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Applying the Addictions Neuroclinical Assessment to derive neurofunctional domains in individuals who use methamphetamine. Behav Brain Res. 2022 06 03; 427:113876. Nieto SJ, Ray LA. PMID: 35378110; PMCID: PMC9150716.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. Moderators of subjective response to alcohol in the human laboratory. Alcohol Clin Exp Res. 2022 03; 46(3):468-476. Nieto SJ, Grodin EN, Ho D, Baskerville WA, Ray LA. PMID: 35084054; PMCID: PMC9153269.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder. Drugs. 2022 Feb; 82(3):251-274. Burnette EM, Nieto SJ, Grodin EN, Meredith LR, Hurley B, Miotto K, Gillis AJ, Ray LA. PMID: 35133639; PMCID: PMC8888464.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    24. A methodological checklist for fMRI drug cue reactivity studies: development and expert consensus. Nat Protoc. 2022 03; 17(3):567-595. Ekhtiari H, Zare-Bidoky M, Sangchooli A, Janes AC, Kaufman MJ, Oliver JA, Prisciandaro JJ, Wüstenberg T, Anton RF, Bach P, Baldacchino A, Beck A, Bjork JM, Brewer J, Childress AR, Claus ED, Courtney KE, Ebrahimi M, Filbey FM, Ghahremani DG, Azbari PG, Goldstein RZ, Goudriaan AE, Grodin EN, Hamilton JP, Hanlon CA, Hassani-Abharian P, Heinz A, Joseph JE, Kiefer F, Zonoozi AK, Kober H, Kuplicki R, Li Q, London ED, McClernon J, Noori HR, Owens MM, Paulus MP, Perini I, Potenza M, Potvin S, Ray L, Schacht JP, Seo D, Sinha R, Smolka MN, Spanagel R, Steele VR, Stein EA, Steins-Loeber S, Tapert SF, Verdejo-Garcia A, Vollstädt-Klein S, Wetherill RR, Wilson SJ, Witkiewitz K, Yuan K, Zhang X, Zilverstand A. PMID: 35121856; PMCID: PMC9063851.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    25. Embedding comprehensive smoking cessation programs into community clinics: study protocol for a cluster-randomized controlled trial. Trials. 2022 Feb 03; 23(1):109. Baskerville WA, Friedman TC, Hurley B, Hsieh S, Dixon T, Mtume N, Lee ML, Rodriguez L, Lopez B, Ray LA. PMID: 35115017; PMCID: PMC8811740.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    26. The relationship between drinking and smoking in a clinical trial for smoking cessation and drinking reduction. Exp Clin Psychopharmacol. 2021 Dec 30. Green R, Montoya AK, Ray LA. PMID: 34968106.
      View in: PubMed   Mentions:    Fields:    
    27. Endotoxin for Alcohol Research: A Call for Experimental Medicine Using Lipopolysaccharide Challenge. Alcohol Alcohol. 2021 Oct 29; 56(6):715-717. Burnette EM, Grodin EN, Eisenberger NI, Ray LA. PMID: 33592623; PMCID: PMC8557676.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. Additive roles of tobacco and cannabis co-use in relation to delay discounting in a sample of heavy drinkers. Psychopharmacology (Berl). 2022 May; 239(5):1387-1395. Nieto SJ, Venegas A, Burnette EM, MacKillop J, Ray LA. PMID: 34652499; PMCID: PMC9059652.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    29. Translational opportunities in animal and human models to study alcohol use disorder. Transl Psychiatry. 2021 09 29; 11(1):496. Nieto SJ, Grodin EN, Aguirre CG, Izquierdo A, Ray LA. PMID: 34588417; PMCID: PMC8481537.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    30. Ibudilast attenuates alcohol cue-elicited frontostriatal functional connectivity in alcohol use disorder. Alcohol Clin Exp Res. 2021 10; 45(10):2017-2028. Burnette EM, Ray LA, Irwin MR, Grodin EN. PMID: 34585396; PMCID: PMC8602728.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    31. Safety Net Provider Attitudes Toward Smoking Cessation Treatment. Front Psychiatry. 2021; 12:744816. Meredith LR, Baskerville WA, Friedman TC, Hurley B, Dixon T, Mtume N, Rodriguez L, Lopez B, Hsieh S, Ray LA. PMID: 34650457; PMCID: PMC8505698.
      View in: PubMed   Mentions:
    32. Alcohol use disorder severity moderates clinical response to varenicline. Alcohol Clin Exp Res. 2021 09; 45(9):1877-1887. Donato S, Green R, Ray LA. PMID: 34486130; PMCID: PMC9059653.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    33. Understanding low treatment seeking rates for alcohol use disorder: A narrative review of the literature and opportunities for improvement. Am J Drug Alcohol Abuse. 2021 11 02; 47(6):664-679. Venegas A, Donato S, Meredith LR, Ray LA. PMID: 34464542; PMCID: PMC9059657.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    34. Cognitive-Behavioral Interventions Targeting Alcohol or Other Drug Use and Co-Occurring Mental Health Disorders: A Meta-Analysis. Alcohol Alcohol. 2021 Aug 30; 56(5):535-544. Mehta K, Hoadley A, Ray LA, Kiluk BD, Carroll KM, Magill M. PMID: 33778869; PMCID: PMC8406071.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    35. Erratum to: Cognitive-Behavioral Interventions Targeting Alcohol or Other Drug Use and Co-Occurring Mental Health Disorders: A Meta-Analysis. Alcohol Alcohol. 2021 Aug 30; 56(5):632. Mehta K, Hoadley A, Ray LA, Kiluk BD, Carroll KM, Magill M. PMID: 33876816; PMCID: PMC8406050.
      View in: PubMed   Mentions:    Fields:    
    36. Effect of alcohol, tobacco, and cannabis co-use on gray matter volume in heavy drinkers. Psychol Addict Behav. 2021 Sep; 35(6):760-768. Grodin EN, Burnette E, Towns B, Venegas A, Ray LA. PMID: 34435833; PMCID: PMC8484037.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    37. Preliminary study of alcohol problem severity and response to brief intervention. Addict Sci Clin Pract. 2021 08 24; 16(1):54. Meredith LR, Grodin EN, Karno MP, Montoya AK, MacKillop J, Lim AC, Ray LA. PMID: 34429151; PMCID: PMC8386030.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    38. Immune treatments for alcohol use disorder: A translational framework. Brain Behav Immun. 2021 10; 97:349-364. Meredith LR, Burnette EM, Grodin EN, Irwin MR, Ray LA. PMID: 34343618; PMCID: PMC9044974.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    39. A genetic association study of tobacco withdrawal endophenotypes in African Americans. Exp Clin Psychopharmacol. 2022 Oct; 30(5):673-681. Leventhal AM, Conti DV, Ray LA, Baurley JW, Bello MS, Cho J, Zhang Y, Pester MS, Lebovitz L, Budiarto A, Mahesworo B, Pardamean B. PMID: 34279980; PMCID: PMC8928755.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    40. A meta-regression of methodological features that predict the effects of medications on the subjective response to alcohol. Alcohol Clin Exp Res. 2021 07; 45(7):1336-1347. Green R, Du H, Grodin EN, Nieto SJ, Bujarski S, Roche DJO, Ray LA. PMID: 34120356; PMCID: PMC9098140.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    41. Combined varenicline and naltrexone attenuates alcohol cue-elicited activation in heavy drinking smokers. Drug Alcohol Depend. 2021 08 01; 225:108825. Grodin EN, Burnette EM, Green R, Lim AC, Miotto K, Ray LA. PMID: 34175784; PMCID: PMC9059649.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    42. Lifetime heavy drinking years predict alcohol use disorder severity over and above current alcohol use. Am J Drug Alcohol Abuse. 2021 09 03; 47(5):630-637. Nieto SJ, Baskerville W, Donato S, Bujarski S, Ray L. PMID: 34134588; PMCID: PMC9053649.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    43. Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial. Transl Psychiatry. 2021 06 12; 11(1):355. Grodin EN, Bujarski S, Towns B, Burnette E, Nieto S, Lim A, Lin J, Miotto K, Gillis A, Irwin MR, Evans C, Ray LA. PMID: 34120149; PMCID: PMC8197758.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    44. Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial. Am J Psychiatry. 2021 09 01; 178(9):818-828. Ray LA, Green R, Enders C, Leventhal AM, Grodin EN, Li G, Lim A, Hartwell E, Venegas A, Meredith L, Nieto SJ, Shoptaw S, Ho D, Miotto K. PMID: 34080890; PMCID: PMC8999864.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    45. Neurobiological Models of Alcohol Use Disorder in Humans. Am J Psychiatry. 2021 06; 178(6):483-484. Ray LA, Green R, Grodin E. PMID: 34154380.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    46. Ibudilast moderates the effect of mood on alcohol craving during stress exposure. Exp Clin Psychopharmacol. 2022 Oct; 30(5):620-631. Meredith LR, Green R, Grodin EN, Chorpita M, Miotto K, Ray LA. PMID: 36102596; PMCID: PMC9484034.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    47. Behavioral Economic Demand for Alcohol and Cigarettes in Heavy Drinking Smokers: Evidence of Asymmetric Cross-commodity Reinforcing Value. Nicotine Tob Res. 2021 03 19; 23(4):748-755. Green R, MacKillop J, Hartwell EE, Lim AC, Baskerville WA, Karno M, Ray LA. PMID: 33247757; PMCID: PMC7976931.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    48. Evaluation of the Addictions Neuroclinical Assessment (ANA) framework through deep phenotyping of problem drinkers. Drug Alcohol Depend. 2021 04 01; 221:108603. Nieto SJ, Grodin EN, Green R, Ray LA. PMID: 33618192; PMCID: PMC8026564.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    49. Clinical Neuroscience of Addiction: What Clinical Psychologists Need to Know and Why. Annu Rev Clin Psychol. 2021 05 07; 17:465-493. Ray LA, Grodin EN. PMID: 33472009.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    50. Baseline Drinking Patterns in Non-Treatment Seeking Problem Drinkers. Alcohol Alcohol. 2021 Jan 04; 56(1):57-63. Baskerville WA, Nieto SJ, Ho D, Towns B, Grodin EN, Li C, Burnette E, Donato S, Ray LA. PMID: 33016306; PMCID: PMC7768624.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    51. Do behavioral pharmacology findings predict clinical trial outcomes? A proof-of-concept in medication development for alcohol use disorder. Neuropsychopharmacology. 2021 02; 46(3):519-527. Ray LA, Du H, Green R, Roche DJO, Bujarski S. PMID: 33235284; PMCID: PMC8026961.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    52. A novel human laboratory model for screening medications for alcohol use disorder. Trials. 2020 Nov 23; 21(1):947. Ho D, Towns B, Grodin EN, Ray LA. PMID: 33225963; PMCID: PMC7681966.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    53. Clinical and Neural Correlates of Reward and Relief Drinking. Alcohol Clin Exp Res. 2021 01; 45(1):194-203. Burnette EM, Grodin EN, Schacht JP, Ray LA. PMID: 33119924; PMCID: PMC7855771.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    54. Diminished cortical response to risk and loss during risky decision making in alcohol use disorder. Drug Alcohol Depend. 2021 01 01; 218:108391. Burnette EM, Grodin EN, Ghahremani DG, Galván A, Kohno M, Ray LA, London ED. PMID: 33153830; PMCID: PMC7750289.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    55. Pain catastrophizing predicts alcohol craving in heavy drinkers independent of pain intensity. Drug Alcohol Depend. 2021 01 01; 218:108368. Nieto SJ, Green R, Grodin EN, Cahill CM, Ray LA. PMID: 33143942; PMCID: PMC7750265.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    56. Mechanisms of Alcohol Addiction: Bridging Human and Animal Studies. Alcohol Alcohol. 2020 Oct 20; 55(6):603-607. Kramer J, Dick DM, King A, Ray LA, Sher KJ, Vena A, Vendruscolo LF, Acion L. PMID: 32781467; PMCID: PMC7576503.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    57. An Exploratory Factor Analysis of the Stimulant, Sedative, and Affective Responses to Alcohol. Alcohol Clin Exp Res. 2020 11; 44(11):2298-2306. Grodin EN, Green RJ, Ray LA. PMID: 32944932.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    58. Intravenous Alcohol Administration Selectively Decreases Rate of Change in Elasticity of Demand in Individuals With Alcohol Use Disorder. Alcohol Clin Exp Res. 2020 11; 44(11):2336-2342. Nieto SJ, Green R, MacKillop J, Ray LA. PMID: 32945536; PMCID: PMC7730832.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    59. Association of frequency of perceived exposure to discrimination with tobacco withdrawal symptoms and smoking lapse behavior in African Americans. Addiction. 2021 04; 116(4):914-925. Bello MS, Liautaud MM, De La Cerda JT, Pang RD, Ray LA, Ahluwalia JA, Leventhal AM. PMID: 32860477; PMCID: PMC7914272.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    60. Ibudilast for alcohol use disorder: study protocol for a phase II randomized clinical trial. Trials. 2020 Sep 11; 21(1):779. Burnette EM, Baskerville WA, Grodin EN, Ray LA. PMID: 32912290; PMCID: PMC7488583.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    61. Neurocognitive performance in alcohol use disorder using the NIH toolbox: Role of severity and sex differences. Drug Alcohol Depend. 2020 11 01; 216:108269. Meredith LR, Lim AC, Ray LA. PMID: 32906037; PMCID: PMC7972314.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    62. Modeling motivation for alcohol in humans using traditional and machine learning approaches. Addict Biol. 2021 05; 26(3):e12949. Grodin EN, Montoya AK, Bujarski S, Ray LA. PMID: 32725863.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    63. Sex-dependent effects of alcohol administration on the urge to use cannabis. Exp Clin Psychopharmacol. 2021 Dec; 29(6):689-695. Venegas A, Meredith LR, Green R, Cooper ZD, Ray LA. PMID: 32658530; PMCID: PMC8409139.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    64. Inclusion of Cannabis Users in Alcohol Research Samples: Screening In, Screening Out, and Implications. Alcohol Alcohol. 2020 Jun 25; 55(4):416-423. Venegas A, Meredith LR, Cooper ZD, Towns B, Ray LA. PMID: 32328657; PMCID: PMC7307319.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    65. Sex-dependent effects of chronic intermittent voluntary alcohol consumption on attentional, not motivational, measures during probabilistic learning and reversal. PLoS One. 2020; 15(6):e0234729. Aguirre CG, Stolyarova A, Das K, Kolli S, Marty V, Ray L, Spigelman I, Izquierdo A. PMID: 32555668; PMCID: PMC7302450.
      View in: PubMed   Mentions: 8     Fields:    Translation:Animals
    66. Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020 06 01; 3(6):e208279. Ray LA, Meredith LR, Kiluk BD, Walthers J, Carroll KM, Magill M. PMID: 32558914; PMCID: PMC7305524.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    67. The search for mechanisms of cognitive behavioral therapy for alcohol or other drug use disorders: A systematic review. Behav Res Ther. 2020 08; 131:103648. Magill M, Tonigan JS, Kiluk B, Ray L, Walthers J, Carroll K. PMID: 32474226; PMCID: PMC7329023.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    68. Alcohol Cue-Induced Ventral Striatum Activity Predicts Subsequent Alcohol Self-Administration. Alcohol Clin Exp Res. 2020 06; 44(6):1224-1233. Lim AC, Green R, Grodin EN, Venegas A, Meredith LR, Donato S, Burnette E, Ray LA. PMID: 32406553; PMCID: PMC7336863.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    69. Executive function moderates naltrexone effects on methamphetamine-induced craving and subjective responses. Am J Drug Alcohol Abuse. 2020 09 02; 46(5):565-576. Lim AC, Grodin EN, Green R, Venegas A, Meredith LR, Courtney KE, Moallem NR, Sayegh P, London ED, Ray LA. PMID: 32343625; PMCID: PMC7920534.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    70. The future of translational research on alcohol use disorder. Addict Biol. 2021 03; 26(2):e12903. Ray LA, Grodin EN, Leggio L, Bechtholt AJ, Becker H, Feldstein Ewing SW, Jentsch JD, King AC, Mason BJ, O'Malley S, MacKillop J, Heilig M, Koob GF. PMID: 32286721; PMCID: PMC7554164.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    71. Preliminary Efficacy of a Cognitive Behavioral Therapy Text Messaging Intervention Targeting Alcohol Use and Antiretroviral Therapy Adherence: A Randomized Clinical Trial. PLoS One. 2020; 15(3):e0229557. Glasner S, Chokron Garneau H, Ang A, Ray L, Venegas A, Rawson R, Kalichman S. PMID: 32163431; PMCID: PMC7067560.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    72. On the path towards personalized medicine: Implications of pharmacogenetic studies of alcohol use disorder medications. Expert Rev Precis Med Drug Dev. 2020; 5(1):43-54. Nieto SJ, Grodin EN, Ray LA. PMID: 34291172; PMCID: PMC8291052.
      View in: PubMed   Mentions:
    73. Acute Effect of Eating Sweets on Alcohol Cravings in a Sample with At-Risk Drinking. Ann Behav Med. 2020 01 24; 54(2):132-138. Cummings JR, Ray LA, Nooteboom P, Tomiyama AJ. PMID: 31504090; PMCID: PMC7309582.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    74. Sensitivity and specificity of a commercial urinary ethyl glucuronide (ETG) test in heavy drinkers. Addict Behav Rep. 2020 Jun; 11:100249. Grodin EN, Nguyen XT, Ho D, Bujarski S, Ray LA. PMID: 32467838; PMCID: PMC7244915.
      View in: PubMed   Mentions: 1  
    75. Reward, Relief and Habit Drinking: Initial Validation of a Brief Assessment Tool. Alcohol Alcohol. 2019 Dec 01; 54(6):574-583. Grodin EN, Bujarski S, Venegas A, Baskerville WA, Nieto SJ, Jentsch JD, Ray LA. PMID: 31557278; PMCID: PMC7306183.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    76. Capturing habitualness of drinking and smoking behavior in humans. Drug Alcohol Depend. 2020 02 01; 207:107738. Ray LA, Du H, Grodin E, Bujarski S, Meredith L, Ho D, Nieto S, Wassum K. PMID: 31816490; PMCID: PMC8063853.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    77. A meta-analysis of cognitive-behavioral therapy for alcohol or other drug use disorders: Treatment efficacy by contrast condition. J Consult Clin Psychol. 2019 Dec; 87(12):1093-1105. Magill M, Ray L, Kiluk B, Hoadley A, Bernstein M, Tonigan JS, Carroll K. PMID: 31599606; PMCID: PMC6856400.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    78. Technology-Delivered Cognitive-Behavioral Interventions for Alcohol Use: A Meta-Analysis. Alcohol Clin Exp Res. 2019 11; 43(11):2285-2295. Kiluk BD, Ray LA, Walthers J, Bernstein M, Tonigan JS, Magill M. PMID: 31566787; PMCID: PMC6824956.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    79. Association between impulsivity and neural activation to alcohol cues in heavy drinkers. Psychiatry Res Neuroimaging. 2019 11 30; 293:110986. Burnette EM, Grodin EN, Lim AC, MacKillop J, Karno MP, Ray LA. PMID: 31622796; PMCID: PMC7238761.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    80. The Use of Functional Magnetic Resonance Imaging to Test Pharmacotherapies for Alcohol Use Disorder: A Systematic Review. Alcohol Clin Exp Res. 2019 10; 43(10):2038-2056. Grodin EN, Ray LA. PMID: 31386215; PMCID: PMC6779480.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    81. The ironic effects of stigmatizing smoking: combining stereotype threat theory with behavioral pharmacology. Addiction. 2019 10; 114(10):1842-1848. Cortland CI, Shapiro JR, Guzman IY, Ray LA. PMID: 31140666.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    82. Is (poly-) substance use associated with impaired inhibitory control? A mega-analysis controlling for confounders. Neurosci Biobehav Rev. 2019 10; 105:288-304. Liu Y, van den Wildenberg WPM, de Graaf Y, Ames SL, Baldacchino A, Bø R, Cadaveira F, Campanella S, Christiansen P, Claus ED, Colzato LS, Filbey FM, Foxe JJ, Garavan H, Hendershot CS, Hester R, Jester JM, Karoly HC, Kräplin A, Kreusch F, Landrø NI, Littel M, Loeber S, London ED, López-Caneda E, Lubman DI, Luijten M, Marczinski CA, Metrik J, Montgomery C, Papachristou H, Mi Park S, Paz AL, Petit G, Prisciandaro JJ, Quednow BB, Ray LA, Roberts CA, Roberts GMP, de Ruiter MB, Rupp CI, Steele VR, Sun D, Takagi M, Tapert SF, van Holst RJ, Verdejo-Garcia A, Vonmoos M, Wojnar M, Yao Y, Yücel M, Zack M, Zucker RA, Huizenga HM, Wiers RW. PMID: 31319124.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    83. Comparing alcohol cue-reactivity in treatment-seekers versus non-treatment-seekers with alcohol use disorder. Am J Drug Alcohol Abuse. 2020; 46(1):131-138. Venegas A, Ray LA. PMID: 31295037.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    84. Convergence between the Penn Alcohol Craving Scale and diagnostic interview for the assessment of alcohol craving. Addict Behav Rep. 2019 Dec; 10:100198. Hartwell EE, Bujarski S, Green R, Ray LA. PMID: 31304230; PMCID: PMC6599943.
      View in: PubMed   Mentions: 3  
    85. An Examination of Motivation to Change and Neural Alcohol Cue Reactivity Following a Brief Intervention. Front Psychiatry. 2019; 10:408. Grodin EN, Lim AC, MacKillop J, Karno MP, Ray LA. PMID: 31244697; PMCID: PMC6580427.
      View in: PubMed   Mentions: 2  
    86. Naltrexone effects on subjective responses to alcohol in the human laboratory: A systematic review and meta-analysis. Addict Biol. 2019 11; 24(6):1138-1152. Ray LA, Green R, Roche DJO, Magill M, Bujarski S. PMID: 31148304; PMCID: PMC6819195.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    87. Neuroimaging findings from an experimental pharmacology trial of naltrexone in heavy drinkers of East Asian descent. Drug Alcohol Depend. 2019 07 01; 200:181-190. Lim AC, Ghahremani DG, Grodin EN, Green R, Bujarski S, Hartwell EE, Courtney KE, Hutchison K, Miotto K, Ray LA. PMID: 31160146; PMCID: PMC6760244.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    88. The Interplay Between Subjective Response to Alcohol, Craving, and Alcohol Self-Administration in the Human Laboratory. Alcohol Clin Exp Res. 2019 05; 43(5):907-915. Green R, Grodin E, Lim AC, Venegas A, Bujarski S, Krull J, Ray LA. PMID: 30860603; PMCID: PMC6519957.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    89. Drug-Induced Craving for Methamphetamine Is Associated With Neural Methamphetamine Cue Reactivity. J Stud Alcohol Drugs. 2019 03; 80(2):245-251. Grodin EN, Courtney KE, Ray LA. PMID: 31014470; PMCID: PMC6489542.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    90. Elucidating the Effect of a Brief Drinking Intervention Using Neuroimaging: A Preliminary Study. Alcohol Clin Exp Res. 2019 02; 43(2):367-377. Grodin EN, Ray LA, MacKillop J, Lim AC, Karno MP. PMID: 30556913; PMCID: PMC6370530.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    91. Naltrexone and alcohol effects on craving for cigarettes in heavy drinking smokers. Exp Clin Psychopharmacol. 2019 Jun; 27(3):257-264. Green R, Bujarski S, Lim AC, Venegas A, Ray LA. PMID: 30628813; PMCID: PMC7227763.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    92. Gabapentin Enacarbil Extended-Release for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multisite Trial Assessing Efficacy and Safety. Alcohol Clin Exp Res. 2019 01; 43(1):158-169. Falk DE, Ryan ML, Fertig JB, Devine EG, Cruz R, Brown ES, Burns H, Salloum IM, Newport DJ, Mendelson J, Galloway G, Kampman K, Brooks C, Green AI, Brunette MF, Rosenthal RN, Dunn KE, Strain EC, Ray L, Shoptaw S, Ait-Daoud Tiouririne N, Gunderson EW, Ransom J, Scott C, Leggio L, Caras S, Mason BJ, Litten RZ, National Institute on Alcohol Abuse and Alcoholism Clinical Investigations Group (NCIG) Study Group. PMID: 30403402; PMCID: PMC6317996.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    93. What defines a clinically meaningful outcome in the treatment of substance use disorders: 'Getting your life back'. Addiction. 2019 01; 114(1):18-20. Ray LA, Lim AC, Shoptaw S. PMID: 30426617.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    94. Distress Tolerance and Craving for Cigarettes Among Heavy Drinking Smokers. J Stud Alcohol Drugs. 2018 11; 79(6):918-928. Lim AC, Roche DJO, Ray LA. PMID: 30573023; PMCID: PMC6308171.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    95. State-of-the-art behavioral and pharmacological treatments for alcohol use disorder. Am J Drug Alcohol Abuse. 2019; 45(2):124-140. Ray LA, Bujarski S, Grodin E, Hartwell E, Green R, Venegas A, Lim AC, Gillis A, Miotto K. PMID: 30373394; PMCID: PMC6430676.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    96. Does the Neuroimmune Modulator Ibudilast Alter Food Craving? Results in a Sample With Alcohol Use Disorder. J Addict Med. 2018 Sep/Oct; 12(5):410-417. Cummings JR, Tomiyama AJ, Ray LA. PMID: 29794557; PMCID: PMC6167170.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    97. A Brief Smoking Cessation Intervention for Heavy Drinking Smokers: Treatment Feasibility and Acceptability. Front Psychiatry. 2018; 9:362. Lim AC, Courtney KE, Moallem NR, Allen VC, Leventhal AM, Ray LA. PMID: 30147661; PMCID: PMC6095957.
      View in: PubMed   Mentions: 2  
    98. Pain as a predictor and consequence of tobacco abstinence effects amongst African American smokers. J Abnorm Psychol. 2018 Oct; 127(7):683-694. Bello MS, McBeth JF, Ditre JW, Kirkpatrick MG, Ray LA, Dunn KE, Leventhal AM. PMID: 30070540; PMCID: PMC7473762.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    99. Overcoming the "Valley of Death" in Medications Development for Alcohol Use Disorder. Alcohol Clin Exp Res. 2018 09; 42(9):1612-1622. Ray LA, Bujarski S, Roche DJO, Magill M. PMID: 29969156; PMCID: PMC6146966.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    100. Examining the Sexual Health Consequences of Alcohol Consumption Among Black Gay and Bisexual Men. Alcohol Clin Exp Res. 2018 Jun 20. Allen VC, Ray LA, Myers HF. PMID: 29924387.
      View in: PubMed   Mentions:    Fields:    
    101. Differences in the subjective and motivational properties of alcohol across alcohol use severity: application of a novel translational human laboratory paradigm. Neuropsychopharmacology. 2018 08; 43(9):1891-1899. Bujarski S, Jentsch JD, Roche DJO, Ramchandani VA, Miotto K, Ray LA. PMID: 29802367; PMCID: PMC6046045.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    102. Craving as a DSM-5 Symptom of Alcohol Use Disorder in Non-Treatment Seekers. Alcohol Alcohol. 2018 May 01; 53(3):235-240. Hartwell EE, Ray LA. PMID: 29145640.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    103. Effects of varenicline on subjective craving and relative reinforcing value of cigarettes. Drug Alcohol Depend. 2018 Jul 01; 188:53-59. Green R, Ray LA. PMID: 29751347.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    104. The relationship between impulsivity and methamphetamine use severity in a community sample. Drug Alcohol Depend. 2018 06 01; 187:1-7. Moallem NR, Courtney KE, Ray LA. PMID: 29626740; PMCID: PMC6410745.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    105. Relationship between tonic and phasic craving for alcohol. Addict Behav Rep. 2018 Jun; 7:71-74. Hartwell EE, Ray LA. PMID: 29892699; PMCID: PMC5993886.
      View in: PubMed   Mentions: 3  
    106. Pharmacogenetic Effects of Naltrexone in Individuals of East Asian Descent: Human Laboratory Findings from a Randomized Trial. Alcohol Clin Exp Res. 2018 Mar; 42(3):613-623. Ray LA, Green R, Roche DJO, Bujarski S, Hartwell EE, Lim AC, Rohrbaugh T, Ghahremani D, Hutchison K, Miotto K. PMID: 29265379; PMCID: PMC6086578.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    107. Development, Initial Testing and Challenges of an Ecologically Valid Reward Prediction Error FMRI Task for Alcoholism. Alcohol Alcohol. 2017 Sep 01; 52(5):617-624. Cservenka A, Courtney KE, Ghahremani DG, Hutchison KE, Ray LA. PMID: 28633363; PMCID: PMC5860006.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    108. Effects of Alcohol Dependence Severity on Neural Correlates of Delay Discounting. Alcohol Alcohol. 2017 Jul 01; 52(4):506-515. Lim AC, Cservenka A, Ray LA. PMID: 28340213.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    109. Barriers to initiation of extended release naltrexone among HIV-infected adults with alcohol use disorders. J Subst Abuse Treat. 2018 02; 85:34-37. Chokron Garneau H, Venegas A, Rawson R, Ray LA, Glasner S. PMID: 28527854; PMCID: PMC5681892.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    110. Differences between treatment-seeking and non-treatment-seeking participants in medication studies for alcoholism: do they matter? Am J Drug Alcohol Abuse. 2017 11; 43(6):703-710. Ray LA, Bujarski S, Yardley MM, Roche DJO, Hartwell EE. PMID: 28426264; PMCID: PMC6159933.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    111. Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder. Psychopharmacology (Berl). 2017 Jul; 234(13):1997-2007. Roche DJO, Worley MJ, Courtney KE, Bujarski S, London ED, Shoptaw S, Ray LA. PMID: 28357460; PMCID: PMC5480611.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    112. Impulsivity Moderates Subjective Responses to Alcohol in Alcohol-Dependent Individuals. Alcohol Alcohol. 2017 Mar 09; 52(2):249-255. Westman JG, Bujarski S, Ray LA. PMID: 28003245; PMCID: PMC5378221.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    113. Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial. Neuropsychopharmacology. 2017 Aug; 42(9):1776-1788. Ray LA, Bujarski S, Shoptaw S, Roche DJ, Heinzerling K, Miotto K. PMID: 28091532; PMCID: PMC5520778.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    114. Severity of alcohol dependence is negatively related to hypothalamic and prefrontal cortical gray matter density in heavy drinking smokers. Am J Drug Alcohol Abuse. 2017 05; 43(3):281-290. Bullock K, Cservenka A, Ray LA. PMID: 27996310; PMCID: PMC5473356.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    115. Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity. Am J Addict. 2017 Aug; 26(5):516-525. Cservenka A, Yardley MM, Ray LA. PMID: 28134463; PMCID: PMC5484746.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    116. Sex Differences in the Association Between Internalizing Symptoms and Craving in Methamphetamine Users. J Addict Med. 2016 Nov/Dec; 10(6):395-401. Hartwell EE, Moallem NR, Courtney KE, Glasner-Edwards S, Ray LA. PMID: 27504928; PMCID: PMC5083163.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    117. Obsessive-compulsive symptoms and negative affect during tobacco withdrawal in a non-clinical sample of African American smokers. J Anxiety Disord. 2017 May; 48:78-86. Bello MS, Pang RD, Chasson GS, Ray LA, Leventhal AM. PMID: 27769664; PMCID: PMC5380588.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    118. Self-reported attentional and motor impulsivity are related to age at first methamphetamine use. Addict Behav. 2017 02; 65:7-12. Cservenka A, Ray LA. PMID: 27701027; PMCID: PMC5382019.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    119. Brain mechanisms of Change in Addictions Treatment: Models, Methods, and Emerging Findings. Curr Addict Rep. 2016 Sep; 3(3):332-342. Chung T, Noronha A, Carroll KM, Potenza MN, Hutchison K, Calhoun VD, Gabrieli JD, Morgenstern J, Nixon SJ, Wexler BE, Brewer J, Ray L, Filbey F, Strauman TJ, Kober H, Feldstein Ewing SW. PMID: 27990326; PMCID: PMC5155705.
      View in: PubMed   Mentions: 15  
    120. The Effects of Pharmacological Opioid Blockade on Neural Measures of Drug Cue-Reactivity in Humans. Neuropsychopharmacology. 2016 11; 41(12):2872-2881. Courtney KE, Ghahremani DG, Ray LA. PMID: 27312405; PMCID: PMC5061897.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    121. Experimental psychopathology paradigms for alcohol use disorders: Applications for translational research. Behav Res Ther. 2016 11; 86:11-22. Bujarski S, Ray LA. PMID: 27266992; PMCID: PMC5067182.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    122. Relationship between negative affect and smoking topography in heavy drinking smokers. Addict Behav. 2016 10; 61:53-7. Green R, Bujarski S, Roche DJ, Ray LA. PMID: 27240211; PMCID: PMC6090554.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    123. A Pilot Study of the Safety and Initial Efficacy of Ivermectin for the Treatment of Alcohol Use Disorder. Alcohol Clin Exp Res. 2016 06; 40(6):1312-20. Roche DJ, Yardley MM, Lunny KF, Louie SG, Davies DL, Miotto K, Ray LA. PMID: 27087145; PMCID: PMC4942320.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    124. Current insights into the mechanisms and development of treatments for heavy drinking cigarette smokers. Curr Addict Rep. 2016 Mar; 3(1):125-137. Roche DJ, Ray LA, Yardley MM, King AC. PMID: 27162709; PMCID: PMC4859339.
      View in: PubMed   Mentions: 22  
    125. Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models. Addict Biol. 2017 May; 22(3):581-615. Yardley MM, Ray LA. PMID: 26833803; PMCID: PMC4969222.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimals
    126. Opioids and social bonding: naltrexone reduces feelings of social connection. Soc Cogn Affect Neurosci. 2016 05; 11(5):728-35. Inagaki TK, Ray LA, Irwin MR, Way BM, Eisenberger NI. PMID: 26796966; PMCID: PMC4847702.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    127. Subjective Response to Alcohol as a Research Domain Criterion. Alcohol Clin Exp Res. 2016 Jan; 40(1):6-17. Ray LA, Bujarski S, Roche DJ. PMID: 26727518.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    128. Attention Deficit/Hyperactivity Disorder (ADHD) Symptoms Predict Alcohol Expectancy Development. J Child Adolesc Subst Abuse. 2016 Mar 01; 25(2):159-179. Squeglia LM, Brammer WA, Ray LA, Lee SS. PMID: 27110089; PMCID: PMC4840407.
      View in: PubMed   Mentions: 4     Fields:    
    129. Development and Preliminary Testing of a Promotora-Delivered, Spanish Language, Counseling Intervention for Heavy Drinking among Male, Latino Day Laborers. J Subst Abuse Treat. 2016 Mar; 62:96-101. Moore AA, Karno MP, Ray L, Ramirez K, Barenstein V, Portillo MJ, Rizo P, Borok J, Liao DH, Barron J, del Pino HE, Valenzuela A, Barry KL. PMID: 26738641; PMCID: PMC4744478.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    130. Food-alcohol competition: As young females eat more food, do they drink less alcohol? J Health Psychol. 2017 04; 22(5):674-683. Cummings JR, Ray LA, Tomiyama AJ. PMID: 26542418.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    131. Clinical neuroscience of amphetamine-type stimulants: From basic science to treatment development. Prog Brain Res. 2016; 223:295-310. Courtney KE, Ray LA. PMID: 26806782.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    132. Neural substrates of cue reactivity: association with treatment outcomes and relapse. Addict Biol. 2016 Jan; 21(1):3-22. Courtney KE, Schacht JP, Hutchison K, Roche DJ, Ray LA. PMID: 26435524; PMCID: PMC4986996.
      View in: PubMed   Mentions: 91     Fields:    Translation:Humans
    133. Genetic and Environmental Predictors of Alcohol Use in Asian American Young Adults. J Stud Alcohol Drugs. 2015 Sep; 76(5):690-9. Bujarski S, Lau AS, Lee SS, Ray LA. PMID: 26402349; PMCID: PMC4714821.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    134. Functional significance of subjective response to alcohol across levels of alcohol exposure. Addict Biol. 2017 Jan; 22(1):235-245. Bujarski S, Hutchison KE, Prause N, Ray LA. PMID: 26256114.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    135. The effect of alcohol priming on neural markers of alcohol cue-reactivity. Am J Drug Alcohol Abuse. 2015; 41(4):300-8. Courtney KE, Ghahremani DG, Ray LA. PMID: 26125586; PMCID: PMC4651007.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    136. Novelty Seeking as a Phenotypic Marker of Adolescent Substance Use. Subst Abuse. 2015; 9(Suppl 1):1-10. Bidwell LC, Knopik VS, Audrain-McGovern J, Glynn TR, Spillane NS, Ray LA, Riggs NR, Guillot CR, Pang RD, Leventhal AM. PMID: 26106262; PMCID: PMC4472033.
      View in: PubMed   Mentions: 13  
    137. The Association of Alcohol Severity and Sleep Quality in Problem Drinkers. Alcohol Alcohol. 2015 Sep; 50(5):536-41. Hartwell EE, Bujarski S, Glasner-Edwards S, Ray LA. PMID: 26018218; PMCID: PMC4537520.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    138. Factor Structure of Subjective Responses to Alcohol in Light and Heavy Drinkers. Alcohol Clin Exp Res. 2015 Jul; 39(7):1193-202. Bujarski S, Hutchison KE, Roche DJ, Ray LA. PMID: 26010049; PMCID: PMC4490987.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    139. Subjective response as a consideration in the pharmacogenetics of alcoholism treatment. Pharmacogenomics. 2015; 16(7):721-36. Roche DJ, Ray LA. PMID: 25950242.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    140. Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers. Pharmacol Biochem Behav. 2015 Jul; 134:92-8. Roche DJ, Bujarski S, Hartwell E, Green R, Ray LA. PMID: 25933795; PMCID: PMC4457679.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    141. Mechanisms of topiramate effects: refining medications development for alcoholism. Addict Biol. 2016 Jan; 21(1):183-184. Ray LA, Bujarski S. PMID: 25876675.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    142. Emotion differentiation and intensity during acute tobacco abstinence: A comparison of heavy and light smokers. Addict Behav. 2015 Aug; 47:70-3. Sheets ES, Bujarski S, Leventhal AM, Ray LA. PMID: 25885662; PMCID: PMC4417388.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    143. A matter of outlook. Alcohol Clin Exp Res. 2015 Apr; 39(4):590. Ray LA. PMID: 25833019.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    144. Modeling naturalistic craving, withdrawal, and affect during early nicotine abstinence: A pilot ecological momentary assessment study. Exp Clin Psychopharmacol. 2015 Apr; 23(2):81-9. Bujarski S, Roche DJ, Sheets ES, Krull JL, Guzman I, Ray LA. PMID: 25844632; PMCID: PMC4388058.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    145. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study. Neuropsychopharmacology. 2015 Sep; 40(10):2347-56. Ray LA, Bujarski S, Courtney KE, Moallem NR, Lunny K, Roche D, Leventhal AM, Shoptaw S, Heinzerling K, London ED, Miotto K. PMID: 25801501; PMCID: PMC4538349.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    146. Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers. CNS Drugs. 2015; 29(10):833-45. Yardley MM, Mirbaba MM, Ray LA. PMID: 26507831; PMCID: PMC4651006.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    147. Behavioral economic analysis of stress effects on acute motivation for alcohol. J Exp Anal Behav. 2015 Jan; 103(1):77-86. Owens MM, Ray LA, MacKillop J. PMID: 25413719.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    148. Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature. Drug Alcohol Depend. 2014 Oct 01; 143:11-21. Courtney KE, Ray LA. PMID: 25176528; PMCID: PMC4164186.
      View in: PubMed   Mentions: 129     Fields:    Translation:Humans
    149. Differences in quit attempts between non-Hispanic Black and White daily smokers: the role of smoking motives. Addict Behav. 2014 Dec; 39(12):1769-72. Bacio GA, Guzman IY, Shapiro JR, Ray LA. PMID: 25123344; PMCID: PMC4320691.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    150. Negative affect is associated with alcohol, but not cigarette use in heavy drinking smokers. Addict Behav. 2014 Dec; 39(12):1723-9. Bujarski S, Ray LA. PMID: 25117849.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    151. Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings. Am J Drug Alcohol Abuse. 2015 Jan; 41(1):35-44. Ray LA, Courtney KE, Ghahremani DG, Miotto K, Brody A, London ED. PMID: 24949564; PMCID: PMC4365972.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    152. The relationship between methamphetamine and alcohol use in a community sample of methamphetamine users. Drug Alcohol Depend. 2014 Sep 01; 142:127-32. Bujarski S, Roche DJ, Lunny K, Moallem NR, Courtney KE, Allen V, Hartwell E, Leventhal A, Rohrbaugh T, Ray LA. PMID: 24975477; PMCID: PMC4157644.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    153. Determinants of problem drinking and depression among Latino Day laborers. Subst Use Misuse. 2014 Jun; 49(8):1039-48. Bacio G, Moore A, Karno M, Ray L. PMID: 24779503; PMCID: PMC4098844.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    154. Modeling behavioral reactivity to losses and rewards on the Balloon Analogue Risk Task (BART): moderation by alcohol problem severity. Exp Clin Psychopharmacol. 2014 Aug; 22(4):298-306. Ashenhurst JR, Bujarski S, Jentsch JD, Ray LA. PMID: 24840639.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    155. The association between cue-reactivity in the precuneus and level of dependence on nicotine and alcohol. Drug Alcohol Depend. 2014 Aug 01; 141:21-6. Courtney KE, Ghahremani DG, London ED, Ray LA. PMID: 24880692; PMCID: PMC4166553.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    156. Predictors of pretreatment commitment to abstinence: results from the COMBINE study. J Stud Alcohol Drugs. 2014 May; 75(3):438-46. DeMartini KS, Devine EG, DiClemente CC, Martin DJ, Ray LA, O'Malley SS. PMID: 24766756; PMCID: PMC4002857.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    157. Subjective response to alcohol and associated craving in heavy drinkers vs. alcohol dependents: an examination of Koob's allostatic model in humans. Drug Alcohol Depend. 2014 Jul 01; 140:161-7. Bujarski S, Ray LA. PMID: 24837580; PMCID: PMC4169206.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    158. Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings. Psychopharmacology (Berl). 2014 Oct; 231(19):3843-53. Ray LA, Courtney KE, Ghahremani DG, Miotto K, Brody A, London ED. PMID: 24733235; PMCID: PMC4161630.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    159. The neuroeconomics of alcohol demand: an initial investigation of the neural correlates of alcohol cost-benefit decision making in heavy drinking men. Neuropsychopharmacology. 2014 Jul; 39(8):1988-95. MacKillop J, Amlung MT, Acker J, Gray JC, Brown CL, Murphy JG, Ray LA, Sweet LH. PMID: 24584331; PMCID: PMC4059908.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    160. Predictors of smoking lapse in a human laboratory paradigm. Psychopharmacology (Berl). 2014 Jul; 231(14):2889-97. Roche DJ, Bujarski S, Moallem NR, Guzman I, Shapiro JR, Ray LA. PMID: 24500677.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    161. Characterizing subjective responses to alcohol among adolescent problem drinkers. J Abnorm Psychol. 2014 Feb; 123(1):117-29. Miranda R, Monti PM, Ray L, Treloar HR, Reynolds EK, Ramirez J, Chun T, Gwaltney CJ, Justus A, Tidey J, Blanchard A, Magill M. PMID: 24661164; PMCID: PMC4102316.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    162. Interactive effects of OPRM1 and DAT1 genetic variation on subjective responses to alcohol. Alcohol Alcohol. 2014 May-Jun; 49(3):261-70. Ray LA, Bujarski S, Squeglia LM, Ashenhurst JR, Anton RF. PMID: 24421289; PMCID: PMC3992909.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    163. Subjective responses to alcohol in the lab predict neural responses to alcohol cues. J Stud Alcohol Drugs. 2014 Jan; 75(1):124-35. Courtney KE, Ray LA. PMID: 24411804; PMCID: PMC3893626.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    164. Opportunities for the development of neuroimmune therapies in addiction. Int Rev Neurobiol. 2014; 118:381-401. Ray LA, Roche DJ, Heinzerling K, Shoptaw S. PMID: 25175870.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimals
    165. Psychiatric correlates of alcohol and tobacco use disorders in U.S. adults aged 65 years and older: results from the 2001-2002 National Epidemiologic Survey of Alcohol and Related Conditions. Am J Geriatr Psychiatry. 2014 Nov; 22(11):1356-63. Lin JC, Karno MP, Grella CE, Ray LA, Liao DH, Moore AA. PMID: 24021218; PMCID: PMC3949218.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    166. Craving and subjective responses to alcohol administration: validation of the desires for alcohol questionnaire in the human laboratory. J Stud Alcohol Drugs. 2013 Sep; 74(5):797-802. Courtney KE, Ashenhurst J, Bacio G, Moallem N, Bujarski S, Hartwell E, Ray LA. PMID: 23948540; PMCID: PMC3749322.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    167. Modeling alcohol use disorder severity: an integrative structural equation modeling approach. Front Psychiatry. 2013; 4:75. Moallem NR, Courtney KE, Bacio GA, Ray LA. PMID: 23908635; PMCID: PMC3725454.
      View in: PubMed   Mentions: 9  
    168. Initial evidence that OPRM1 genotype moderates ventral and dorsal striatum functional connectivity during alcohol cues. Alcohol Clin Exp Res. 2014 Jan; 38(1):78-89. Ray LA, Courtney KE, Hutchison KE, Mackillop J, Galvan A, Ghahremani DG. PMID: 23876228; PMCID: PMC3808494.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    169. Sex moderates stress reactivity in heavy drinkers. Addict Behav. 2013 Nov; 38(11):2643-6. Hartwell EE, Ray LA. PMID: 23899426.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    170. Alcohol use following an alcohol challenge and a brief intervention among alcohol-dependent individuals. Am J Addict. 2014 Jan-Feb; 23(1):96-101. Bacio GA, Lunny KF, Webb JN, Ray LA. PMID: 24313247.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    171. The CRHR1 gene, trauma exposure, and alcoholism risk: a test of G × E effects. Genes Brain Behav. 2013 Jun; 12(4):361-9. Ray LA, Sehl M, Bujarski S, Hutchison K, Blaine S, Enoch MA. PMID: 23473364; PMCID: PMC4139150.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    172. Effects of naltrexone on adolescent alcohol cue reactivity and sensitivity: an initial randomized trial. Addict Biol. 2014 Sep; 19(5):941-54. Miranda R, Ray L, Blanchard A, Reynolds EK, Monti PM, Chun T, Justus A, Swift RM, Tidey J, Gwaltney CJ, Ramirez J. PMID: 23489253; PMCID: PMC3729253.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    173. The effects of varenicline on stress-induced and cue-induced craving for cigarettes. Drug Alcohol Depend. 2013 Jul 01; 131(1-2):136-42. Ray LA, Lunny K, Bujarski S, Moallem N, Krull JL, Miotto K. PMID: 23298651.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    174. Subjective response to alcohol among alcohol-dependent individuals: effects of the μ-opioid receptor (OPRM1) gene and alcoholism severity. Alcohol Clin Exp Res. 2013 Jan; 37 Suppl 1:E116-24. Ray LA, Bujarski S, MacKillop J, Courtney KE, Monti PM, Miotto K. PMID: 23240711; PMCID: PMC3548029.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    175. Fronto-striatal functional connectivity during response inhibition in alcohol dependence. Addict Biol. 2013 May; 18(3):593-604. Courtney KE, Ghahremani DG, Ray LA. PMID: 23240858; PMCID: PMC3683582.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    176. The effects of drinking goal on treatment outcome for alcoholism. J Consult Clin Psychol. 2013 Feb; 81(1):13-22. Bujarski S, O'Malley SS, Lunny K, Ray LA. PMID: 23231573; PMCID: PMC4166539.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    177. Integration of behavioral medicine in primary care. Prim Care. 2012 Dec; 39(4):605-14. Bholat MA, Ray L, Brensilver M, Ling K, Shoptaw S. PMID: 23148953.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    178. Preliminary evidence for a gene-environment interaction in predicting alcohol use disorders in adolescents. Alcohol Clin Exp Res. 2013 Feb; 37(2):325-31. Miranda R, Reynolds E, Ray L, Justus A, Knopik VS, McGeary J, Meyerson LA. PMID: 23136901; PMCID: PMC3700411.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    179. Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol. Pharmacol Biochem Behav. 2012 Dec; 103(2):253-9. Ashenhurst JR, Bujarski S, Ray LA. PMID: 22954510; PMCID: PMC3683577.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    180. The neuroeconomics of nicotine dependence: a preliminary functional magnetic resonance imaging study of delay discounting of monetary and cigarette rewards in smokers. Psychiatry Res. 2012 Apr 30; 202(1):20-9. MacKillop J, Amlung MT, Wier LM, David SP, Ray LA, Bickel WK, Sweet LH. PMID: 22633679; PMCID: PMC3530421.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    181. Understanding naltrexone mechanism of action and pharmacogenetics in Asian Americans via behavioral economics: a preliminary study. Exp Clin Psychopharmacol. 2012 Jun; 20(3):181-90. Bujarski S, MacKillop J, Ray LA. PMID: 22429255; PMCID: PMC3741097.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    182. Dimensions of impulsivity among heavy drinkers, smokers, and heavy drinking smokers: singular and combined effects. Addict Behav. 2012 Jul; 37(7):871-4. Moallem NR, Ray LA. PMID: 22445419; PMCID: PMC3741101.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    183. A prospective study of stress and alcohol craving in heavy drinkers. Pharmacol Biochem Behav. 2012 Jun; 101(4):625-31. Tartter MA, Ray LA. PMID: 22446386.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    184. Human laboratory paradigms in alcohol research. Alcohol Clin Exp Res. 2012 Jun; 36(6):972-83. Plebani JG, Ray LA, Morean ME, Corbin WR, MacKillop J, Amlung M, King AC. PMID: 22309888; PMCID: PMC4167612.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    185. COMT Val158Met, BDNF Val66Met, and OPRM1 Asn40Asp and methamphetamine dependence treatment response: preliminary investigation. J Clin Psychopharmacol. 2012 Feb; 32(1):135-7. Heinzerling KG, McCracken JT, Swanson AN, Ray LA, Shoptaw SJ. PMID: 22217949; PMCID: PMC3597465.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    186. Pharmacogenetics of alcoholism: a clinical neuroscience perspective. Pharmacogenomics. 2012 Jan; 13(2):129-32. Ray LA, Courtney KE, Bujarski S, Squeglia LM. PMID: 22256863; PMCID: PMC3683583.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    187. Genetic and environmental influences on the association between depressive symptom dimensions and smoking initiation among Chinese adolescent twins. Nicotine Tob Res. 2012 May; 14(5):559-68. Leventhal AM, Ray LA, Rhee SH, Unger JB. PMID: 22180578; PMCID: PMC3337537.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    188. Quetiapine improves response inhibition in alcohol dependent patients: a placebo-controlled pilot study. Pharmacol Biochem Behav. 2012 Jan; 100(3):490-3. Moallem N, Ray LA. PMID: 22037407; PMCID: PMC3741103.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    189. The relationship between measures of impulsivity and alcohol misuse: an integrative structural equation modeling approach. Alcohol Clin Exp Res. 2012 Jun; 36(6):923-31. Courtney KE, Arellano R, Barkley-Levenson E, Gálvan A, Poldrack RA, Mackillop J, Jentsch JD, Ray LA. PMID: 22091877; PMCID: PMC3291799.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    190. Risk-taking and alcohol use disorders symptomatology in a sample of problem drinkers. Exp Clin Psychopharmacol. 2011 Oct; 19(5):361-70. Ashenhurst JR, Jentsch JD, Ray LA. PMID: 21707191; PMCID: PMC4166528.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    191. New approaches to identifying rare genetic variants associated with nicotine dependence. Biol Psychiatry. 2011 Sep 15; 70(6):500-1. Hutchison KE, Ray LA. PMID: 21864734.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    192. Pharmacogenetics of naltrexone in asian americans: a randomized placebo-controlled laboratory study. Neuropsychopharmacology. 2012 Jan; 37(2):445-55. Ray LA, Bujarski S, Chin PF, Miotto K. PMID: 21900886; PMCID: PMC3242306.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    193. The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review. Alcohol Clin Exp Res. 2012 Mar; 36(3):385-94. Ray LA, Barr CS, Blendy JA, Oslin D, Goldman D, Anton RF. PMID: 21895723; PMCID: PMC3249007.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansAnimals
    194. The Serotonin Transporter Polymorphism (5-HTTLPR) and Alcohol Problems in Heavy Drinkers: Moderation by Depressive Symptoms. Front Psychiatry. 2011; 2:49. Tartter MA, Ray LA. PMID: 21852976; PMCID: PMC3151606.
      View in: PubMed   Mentions: 4  
    195. A human laboratory study of the effects of quetiapine on subjective intoxication and alcohol craving. Psychopharmacology (Berl). 2011 Oct; 217(3):341-51. Ray LA, Chin PF, Heydari A, Miotto K. PMID: 21487653.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    196. Delayed reward discounting and addictive behavior: a meta-analysis. Psychopharmacology (Berl). 2011 Aug; 216(3):305-21. MacKillop J, Amlung MT, Few LR, Ray LA, Sweet LH, Munafò MR. PMID: 21373791; PMCID: PMC3201846.
      View in: PubMed   Mentions: 427     Fields:    Translation:Humans
    197. Binge eating and binge drinking: an integrative review. Eat Behav. 2011 Apr; 12(2):99-107. Ferriter C, Ray LA. PMID: 21385638.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    198. Clinical correlates of desire for treatment for current alcohol dependence among patients with a primary psychiatric disorder. Am J Drug Alcohol Abuse. 2011 Mar; 37(2):105-10. Ray LA, Hart E, Chelminski I, Young D, Zimmerman M. PMID: 21219256; PMCID: PMC3741090.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    199. Anhedonia associated with stimulant use and dependence in a population-based sample of American adults. Exp Clin Psychopharmacol. 2010 Dec; 18(6):562-9. Leventhal AM, Brightman M, Ameringer KJ, Greenberg J, Mickens L, Ray LA, Sun P, Sussman S. PMID: 21186931; PMCID: PMC3307593.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    200. Self-Rating of the Effects of Alcohol (SRE): Predictive utility and reliability across interview and self-report administrations. Addict Behav. 2011 Mar; 36(3):241-3. Ray LA, Hart EJ, Chin PF. PMID: 21095629.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    201. The Effects of Naltrexone Among Alcohol Non-Abstainers: Results from the COMBINE Study. Front Psychiatry. 2010; 1:26. Ray LA, Krull JL, Leggio L. PMID: 21423437; PMCID: PMC3059647.
      View in: PubMed   Mentions: 12  
    202. Stress-induced and cue-induced craving for alcohol in heavy drinkers: Preliminary evidence of genetic moderation by the OPRM1 and CRH-BP genes. Alcohol Clin Exp Res. 2011 Jan; 35(1):166-74. Ray LA. PMID: 21039637.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    203. Subjective responses to alcohol consumption as endophenotypes: advancing behavioral genetics in etiological and treatment models of alcoholism. Subst Use Misuse. 2010 Sep; 45(11):1742-65. Ray LA, Mackillop J, Monti PM. PMID: 20590398; PMCID: PMC4703313.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    204. Quetiapine for the treatment of alcoholism: scientific rationale and review of the literature. Drug Alcohol Rev. 2010 Sep; 29(5):568-75. Ray LA, Heydari A, Zorick T. PMID: 20887583.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    205. Behavioral economic analysis of cue-elicited craving for alcohol. Addiction. 2010 Sep; 105(9):1599-607. MacKillop J, O'Hagen S, Lisman SA, Murphy JG, Ray LA, Tidey JW, McGeary JE, Monti PM. PMID: 20626376; PMCID: PMC4853028.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    206. Naltrexone selectively elevates GABAergic neuroactive steroid levels in heavy drinkers with the Asp40 allele of the OPRM1 gene: a pilot investigation. Alcohol Clin Exp Res. 2010 Aug; 34(8):1479-87. Ray LA, Hutchison KE, Ashenhurst JR, Morrow AL. PMID: 20528823.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    207. Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics. CNS Neurol Disord Drug Targets. 2010 Mar; 9(1):13-22. Ray LA, Chin PF, Miotto K. PMID: 20201811.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    208. Polymorphisms of the mu-opioid receptor and dopamine D4 receptor genes and subjective responses to alcohol in the natural environment. J Abnorm Psychol. 2010 Feb; 119(1):115-25. Ray LA, Miranda R, Tidey JW, McGeary JE, MacKillop J, Gwaltney CJ, Rohsenow DJ, Swift RM, Monti PM. PMID: 20141248; PMCID: PMC3703617.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansCells
    209. Alcohol demand, delayed reward discounting, and craving in relation to drinking and alcohol use disorders. J Abnorm Psychol. 2010 Feb; 119(1):106-14. MacKillop J, Miranda R, Monti PM, Ray LA, Murphy JG, Rohsenow DJ, McGeary JE, Swift RM, Tidey JW, Gwaltney CJ. PMID: 20141247; PMCID: PMC2862264.
      View in: PubMed   Mentions: 156     Fields:    Translation:Humans
    210. Application of human laboratory models to pharmacotherapy development for alcohol dependence. Curr Pharm Des. 2010; 16(19):2149-58. Ray LA, Hutchison KE, Tartter M. PMID: 20482505.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimals
    211. Posttraumatic stress disorder with and without alcohol use disorders: diagnostic and clinical correlates in a psychiatric sample. Psychiatry Res. 2009 Dec 30; 170(2-3):278-81. Ray LA, Capone C, Sheets E, Young D, Chelminski I, Zimmerman M. PMID: 19900714; PMCID: PMC3418967.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    212. Young Investigator Award symposium. Alcohol. 2009 Nov; 43(7):499-508. Witkiewitz K, Holmes A, Ray LA, Murphy JG, Richardson HN, Chen YC, McDevitt-Murphy ME, Cruz MT, Roberto M. PMID: 19913193.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    213. Initial evidence of an association between OPRM1 and adolescent alcohol misuse. Alcohol Clin Exp Res. 2010 Jan; 34(1):112-22. Miranda R, Ray L, Justus A, Meyerson LA, Knopik VS, McGeary J, Monti PM. PMID: 19860800; PMCID: PMC3691683.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    214. Catching the alcohol buzz: an examination of the latent factor structure of subjective intoxication. Alcohol Clin Exp Res. 2009 Dec; 33(12):2154-61. Ray LA, MacKillop J, Leventhal A, Hutchison KE. PMID: 19764932; PMCID: PMC3081518.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    215. Naltrexone for the treatment of alcohol dependence among African Americans: results from the COMBINE Study. Drug Alcohol Depend. 2009 Dec 01; 105(3):256-8. Ray LA, Oslin DW. PMID: 19717248; PMCID: PMC3409877.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    216. Relations between anhedonia and smoking motivation. Nicotine Tob Res. 2009 Sep; 11(9):1047-54. Leventhal AM, Waters AJ, Kahler CW, Ray LA, Sussman S. PMID: 19571250; PMCID: PMC2725007.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansPHPublic Health
    217. Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. J Stud Alcohol Drugs. 2009 Jul; 70(4):516-27. Magill M, Ray LA. PMID: 19515291; PMCID: PMC2696292.
      View in: PubMed   Mentions: 165     Fields:    Translation:Humans
    218. Blood glucose level, alcohol heavy drinking, and alcohol craving during treatment for alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) Study. Alcohol Clin Exp Res. 2009 Sep; 33(9):1539-44. Leggio L, Ray LA, Kenna GA, Swift RM. PMID: 19485973; PMCID: PMC2955866.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    219. Associations among GABRG1, level of response to alcohol, and drinking behaviors. Alcohol Clin Exp Res. 2009 Aug; 33(8):1382-90. Ray LA, Hutchison KE. PMID: 19426171; PMCID: PMC2965732.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    220. A preliminary pharmacogenetic investigation of adverse events from topiramate in heavy drinkers. Exp Clin Psychopharmacol. 2009 Apr; 17(2):122-9. Ray LA, Miranda R, MacKillop J, McGeary J, Tidey JW, Rohsenow DJ, Gwaltney C, Swift RW, Monti PM. PMID: 19331489; PMCID: PMC3682424.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    221. Diagnosing alcohol abuse in alcohol dependent individuals: diagnostic and clinical implications. Addict Behav. 2009 Jun-Jul; 34(6-7):587-92. Ray LA, Hutchison KE, Leventhal AM, Miranda R, Francione C, Chelminski I, Young D, Zimmerman M. PMID: 19362427; PMCID: PMC3741094.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    222. Refining the depression-nicotine dependence link: patterns of depressive symptoms in psychiatric outpatients with current, past, and no history of nicotine dependence. Addict Behav. 2009 Mar; 34(3):297-303. Leventhal AM, Kahler CW, Ray LA, Zimmerman M. PMID: 19062199; PMCID: PMC2648971.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    223. Latent structure of facets of alcohol reinforcement from a behavioral economic demand curve. Psychopharmacology (Berl). 2009 Mar; 203(1):33-40. Mackillop J, Murphy JG, Tidey JW, Kahler CW, Ray LA, Bickel WK. PMID: 18925387; PMCID: PMC2774887.
      View in: PubMed   Mentions: 79     Fields:    Translation:Humans
    224. Effects of naltrexone on cortisol levels in heavy drinkers. Pharmacol Biochem Behav. 2009 Feb; 91(4):489-94. Ray LA, Mackillop J, Leggio L, Morgan M, Hutchison KE. PMID: 18824022; PMCID: PMC3660224.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    225. The dopamine D Receptor (DRD4) gene exon III polymorphism, problematic alcohol use and novelty seeking: direct and mediated genetic effects. Addict Biol. 2009 Apr; 14(2):238-44. Ray LA, Bryan A, Mackillop J, McGeary J, Hesterberg K, Hutchison KE. PMID: 18715282; PMCID: PMC3151559.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    226. Effects of naltrexone during the descending limb of the blood alcohol curve. Am J Addict. 2008 Jul-Aug; 17(4):257-64. Ray LA, Hutchison KE, MacKillop J, Miranda R, Audette A, Swift R, Monti PM. PMID: 18612879.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    227. Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes. Alcohol Clin Exp Res. 2008 Jul; 32(7):1113-23. Filbey FM, Ray L, Smolen A, Claus ED, Audette A, Hutchison KE. PMID: 18540916; PMCID: PMC2856650.
      View in: PubMed   Mentions: 86     Fields:    Translation:HumansCells
    228. The factor structure and severity of DSM-IV alcohol abuse and dependence symptoms in psychiatric outpatients. J Stud Alcohol Drugs. 2008 Jul; 69(4):496-9. Ray LA, Kahler CW, Young D, Chelminski I, Zimmerman M. PMID: 18612564; PMCID: PMC3741100.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    229. Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorder. Am J Addict. 2008 May-Jun; 17(3):218-23. Leventhal AM, Kahler CW, Ray LA, Stone K, Young D, Chelminski I, Zimmerman M. PMID: 18463999; PMCID: PMC2650808.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    230. Diagnostic orphans for alcohol use disorders in a treatment-seeking psychiatric sample. Drug Alcohol Depend. 2008 Jul 01; 96(1-2):187-91. Ray LA, Miranda R, Chelminski I, Young D, Zimmerman M. PMID: 18430524; PMCID: PMC3741088.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    231. Further validation of a cigarette purchase task for assessing the relative reinforcing efficacy of nicotine in college smokers. Exp Clin Psychopharmacol. 2008 Feb; 16(1):57-65. MacKillop J, Murphy JG, Ray LA, Eisenberg DT, Lisman SA, Lum JK, Wilson DS. PMID: 18266552.
      View in: PubMed   Mentions: 139     Fields:    Translation:Humans
    232. Effects of topiramate on urge to drink and the subjective effects of alcohol: a preliminary laboratory study. Alcohol Clin Exp Res. 2008 Mar; 32(3):489-97. Miranda R, MacKillop J, Monti PM, Rohsenow DJ, Tidey J, Gwaltney C, Swift R, Ray L, McGeary J. PMID: 18215213.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    233. Effects of repeated days of smoking cue exposure on urge to smoke and physiological reactivity. Addict Behav. 2008 Feb; 33(2):347-53. Miranda R, Rohsenow DJ, Monti PM, Tidey J, Ray L. PMID: 17913381; PMCID: PMC2254225.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    234. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. Arch Gen Psychiatry. 2007 Sep; 64(9):1069-77. Ray LA, Hutchison KE. PMID: 17768272.
      View in: PubMed   Mentions: 134     Fields:    Translation:HumansCTClinical Trials
    235. Examining the heritability of a laboratory-based smoking endophenotype: initial results from an experimental twin study. Twin Res Hum Genet. 2007 Aug; 10(4):546-53. Ray LA, Rhee SH, Stallings MC, Knopik V, Hutchison KE. PMID: 17708695.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    236. Pharmacological effects of naltrexone and intravenous alcohol on craving for cigarettes among light smokers: a pilot study. Psychopharmacology (Berl). 2007 Sep; 193(4):449-56. Ray LA, Miranda R, Kahler CW, Leventhal AM, Monti PM, Swift R, Hutchison KE. PMID: 17484067.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    237. Alcohol use and protective sexual behaviors among high-risk adolescents. J Stud Alcohol Drugs. 2007 May; 68(3):327-35. Bryan A, Ray LA, Cooper ML. PMID: 17446971.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    238. Pharmacogenetics of the µ-opioid receptor and the treatment of addictions. Per Med. 2007 May; 4(2):217-220. Ray LA, MacKillop J, Hutchison KE. PMID: 29788631.
      View in: PubMed   Mentions:    Fields:    
    239. The relationship between prospective self-rating of alcohol sensitivity and craving and experimental results from two alcohol challenge studies. J Stud Alcohol Drugs. 2007 May; 68(3):379-84. Ray LA, Meskew-Stacer S, Hutchison KE. PMID: 17446977.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    240. The effect of olanzapine on craving and alcohol consumption. Neuropsychopharmacology. 2006 Jun; 31(6):1310-7. Hutchison KE, Ray L, Sandman E, Rutter MC, Peters A, Davidson D, Swift R. PMID: 16237394.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCellsCTClinical Trials
    241. Risk factors for alcohol misuse: examining heart rate reactivity to alcohol, alcohol sensitivity, and personality constructs. Addict Behav. 2006 Nov; 31(11):1959-73. Ray LA, McGeary J, Marshall E, Hutchison KE. PMID: 16466861.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    242. Alcoholism: the dissection for endophenotypes. Dialogues Clin Neurosci. 2005; 7(2):153-63. Hines LM, Ray L, Hutchison K, Tabakoff B. PMID: 16262210; PMCID: PMC3181729.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    243. A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans. Alcohol Clin Exp Res. 2004 Dec; 28(12):1789-95. Ray LA, Hutchison KE. PMID: 15608594.
      View in: PubMed   Mentions: 157     Fields:    Translation:Humans
    244. Biological and behavioral markers of alcohol sensitivity. Alcohol Clin Exp Res. 2004 Feb; 28(2):247-56. Fromme K, de Wit H, Hutchison KE, Ray L, Corbin WR, Cook TA, Wall TL, Goldman D. PMID: 15112932.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    With one click, see people who:

    Run Clinical Trials

    See more options in the Advanced Search tab

    Lara's Networks
    Concepts (411)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (39)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version pre_new_search-4-g7119b7be on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California